无放大CRISPR-Cas系统集成离心数字微流体平台 开发用于多重呼吸道病原体核酸分析
Jing Zhang1, Longjie Li1, Yidan Zhu1
1Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Analytical chemistry
|November 16, 2025
概括
这项研究开发了CRISPR-Cas9/Cas13a数字微流体芯片,用于快速,灵敏地检测MRSA和H1N1等呼吸道病原体. 该平台提供高精度,没有预放大,非常适合资源有限的设置.
科学领域:
- 生物技术是生物技术.
- 分子诊断学 分子诊断学
- 生物工程是生物工程.
背景情况:
- 传统的PCR需要专门的设备和人员.
- 现有的同热放大方法可以产生假阳性.
- 敏感的CRISPR检测通常需要核酸预放大.
研究的目的:
- 在离心式数字微流体芯片上开发一个集成的CRISPR-Cas9/Cas13a检测平台.
- 克服当前呼吸道传染病诊断技术的局限性.
- 为了实现快速,灵敏和准确的多重病原体检测.
主要方法:
- 开发和优化一个离芯片的CRISPR-Cas9/Cas13a双核酸检测系统.
- 设计和选一个最佳的离心数字微流体芯片结构.
- 将优化的CRISPR系统集成到数字芯片中,用于病原体检测.
主要成果:
- 在芯片外实现了MRSA DNA (173 pM) 和H1N1 RNA (117 pM) 的特定检测.
- 优化的芯片实现了99.6%的滴滴填充率.
- 在20分钟内,芯片上检测达到子拷贝灵敏度 (MRSA为0.7副本/μL,H1N1为1.2副本/μL).
- 在模拟的临床样本中,对阳性和阴性检测的100%准确性得到证明.
结论:
- 集成的平台使灵敏,快速和准确的多重检测呼吸道病原体,没有预放大.
- 这种方便,具有成本效益和抗污染的方法适用于资源有限的场景.
- 该技术为预防和控制传染病提供了可靠的解决方案.
相关概念视频
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:28CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...